Profile data is unavailable for this security.
About the company
UFP Technologies, Inc. is a designer and custom manufacturer of comprehensive solutions for medical devices, sterile packaging, and other engineered custom products. The Company's single-use and single-patient devices and components are used in a range of medical devices and packaging for minimally invasive surgery, infection prevention, surfaces and support, wound care, wearables, orthopedic soft goods, and orthopedic implants. The Company is diversified by also providing engineered products and components to customers in the automotive, aerospace and defense, and industrial/other markets. Typical applications of its products include military uniform and gear components, automotive interior trim, air filtration, and protective cases and inserts. It also engineers’ components for automotive use, such as interior trim and structural applications. These components are produced using a compression molding process. It also develops and manufactures single-use safe patient handling systems.
- Revenue in USD (TTM)407.33m
- Net income in USD47.88m
- Incorporated1993
- Employees3.09k
- LocationUFP Technologies Inc100 Hale StreetNEWBURYPORT 01950United StatesUSA
- Phone+1 (978) 352-2200
- Websitehttps://www.ufpt.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Novocure Ltd | 525.66m | -192.74m | 1.81bn | 1.45k | -- | 5.03 | -- | 3.44 | -1.81 | -1.81 | 4.92 | 3.34 | 0.4579 | 3.57 | 7.51 | 361,774.90 | -16.79 | -7.74 | -19.40 | -8.95 | 74.82 | 77.22 | -36.67 | -14.69 | 5.99 | -- | 0.6132 | -- | -5.30 | 15.47 | -123.75 | -- | 32.19 | -- |
| LeMaitre Vascular Inc | 199.89m | 33.95m | 1.82bn | 614.00 | 53.79 | 5.91 | 41.90 | 9.12 | 1.51 | 1.51 | 8.89 | 13.74 | 0.5977 | 1.17 | 7.19 | 325,548.90 | 10.15 | 9.02 | 10.99 | 9.93 | 66.45 | 65.83 | 16.99 | 15.45 | 5.31 | -- | 0.00 | 40.41 | 19.69 | 12.88 | 45.89 | 5.96 | 18.93 | 15.51 |
| Warby Parker Inc | 697.80m | -55.06m | 1.91bn | 2.14k | -- | 6.02 | -- | 2.73 | -0.467 | -0.467 | 5.91 | 2.66 | 1.21 | 5.19 | 655.52 | 326,074.80 | -9.57 | -- | -11.95 | -- | 55.01 | 57.49 | -7.89 | -14.53 | 2.02 | -- | 0.00 | -- | 11.98 | 19.67 | 42.75 | -- | -- | -- |
| Premier Inc | 1.34bn | 80.33m | 1.94bn | 2.80k | 28.81 | 1.01 | 9.85 | 1.45 | 0.6421 | 0.6421 | 11.34 | 18.35 | 0.3887 | 5.25 | 3.10 | 477,306.10 | 1.89 | 10.39 | 2.48 | 13.00 | 66.20 | 62.04 | 4.87 | 22.60 | 0.8226 | 143.62 | 0.276 | 19.11 | -6.76 | 2.44 | -34.17 | -15.30 | -2.29 | -- |
| Conmed Corp | 1.26bn | 82.35m | 2.06bn | 4.00k | 25.57 | 2.42 | 13.38 | 1.64 | 2.62 | 2.62 | 40.12 | 27.76 | 0.545 | 1.73 | 5.55 | 315,387.00 | 3.56 | 0.8972 | 4.10 | 1.02 | 54.92 | 54.95 | 6.53 | 1.65 | 1.08 | 3.65 | 0.5369 | 139.16 | 19.06 | 7.68 | 179.99 | 10.04 | 2.89 | 0.00 |
| Patterson Companies, Inc. | 6.57bn | 185.93m | 2.10bn | 7.60k | 11.96 | 2.14 | 7.67 | 0.3196 | 2.00 | 2.00 | 70.16 | 11.16 | 2.27 | 6.58 | 12.82 | 864,246.30 | 6.42 | 1.13 | 11.05 | 1.81 | 21.01 | 20.98 | 2.82 | 0.5157 | 0.7473 | 14.91 | 0.389 | 304.75 | 1.50 | 3.34 | -10.42 | 18.10 | 2.17 | 0.00 |
| Quidelortho Corp | 2.86bn | -1.76bn | 2.10bn | 7.10k | -- | 0.6333 | -- | 0.7337 | -26.38 | -26.38 | 42.82 | 49.52 | 0.3696 | 2.67 | 8.92 | 403,197.20 | -22.79 | 11.34 | -25.57 | 12.91 | 48.13 | 62.71 | -61.65 | 20.93 | 0.807 | 0.8786 | 0.4207 | 0.00 | -8.21 | 41.83 | -101.84 | -- | 45.87 | -- |
| UFP Technologies Inc | 407.33m | 47.88m | 2.18bn | 3.09k | 45.69 | 7.38 | 36.56 | 5.34 | 6.21 | 6.21 | 52.82 | 38.46 | 1.02 | 4.50 | 6.71 | 131,693.20 | 11.99 | 9.69 | 13.80 | 10.95 | 27.89 | 26.33 | 11.75 | 10.14 | 1.46 | 17.87 | 0.1039 | 0.00 | 13.08 | 16.00 | 7.50 | 25.71 | 14.08 | -- |
| STAAR Surgical Co | 326.24m | 15.30m | 2.19bn | 1.06k | 143.92 | 5.57 | 105.68 | 6.70 | 0.3093 | 0.3093 | 6.62 | 8.00 | 0.7159 | 2.11 | 5.09 | 308,942.30 | 3.36 | 6.77 | 3.82 | 7.90 | 78.51 | 76.89 | 4.69 | 9.16 | 5.22 | -- | 0.0004 | 0.00 | 13.37 | 21.07 | -46.18 | 33.85 | 51.95 | -- |
| Rxsight Inc | 101.10m | -44.50m | 2.22bn | 374.00 | -- | 12.93 | -- | 21.97 | -1.25 | -1.25 | 2.83 | 4.41 | 0.5243 | 2.01 | 5.91 | 270,323.50 | -23.07 | -- | -25.25 | -- | 63.39 | -- | -44.01 | -- | 8.18 | -- | 0.0009 | -- | 81.77 | -- | 27.19 | -- | -- | -- |
| Evolent Health Inc | 2.18bn | -141.23m | 2.24bn | 4.70k | -- | 2.11 | -- | 1.03 | -1.25 | -1.25 | 19.28 | 10.72 | 0.8316 | -- | 6.30 | 462,948.70 | -4.22 | -9.60 | -5.36 | -12.59 | 20.56 | 24.50 | -5.07 | -13.66 | -- | -0.0548 | 0.3272 | -- | 45.26 | 25.65 | -660.71 | -- | -6.18 | -- |
| Myriad Genetics, Inc. | 774.20m | -234.60m | 2.24bn | 2.70k | -- | 2.95 | -- | 2.89 | -2.82 | -2.82 | 9.11 | 8.40 | 0.6792 | 10.41 | 6.53 | 286,740.80 | -20.58 | -- | -23.57 | -- | 68.79 | -- | -30.30 | -- | 1.82 | -225.20 | 0.0485 | -- | 11.03 | -- | -135.09 | -- | -- | -- |
| 10X Genomics Inc | 625.45m | -264.30m | 2.26bn | 1.26k | -- | 3.14 | -- | 3.61 | -2.24 | -2.24 | 5.30 | 6.01 | 0.6458 | 2.67 | 7.39 | 496,781.60 | -27.29 | -25.52 | -30.80 | -29.05 | 64.62 | 75.88 | -42.26 | -48.53 | 4.45 | -- | 0.00 | -- | 19.81 | 33.43 | -53.67 | -- | 49.15 | -- |
| Integra Lifesciences Holdings Corp | 1.53bn | 40.23m | 2.30bn | 3.95k | 57.47 | 1.44 | 14.10 | 1.50 | 0.5079 | 0.5079 | 19.32 | 20.29 | 0.3912 | 1.56 | 6.06 | 387,632.80 | 1.03 | 3.33 | 1.11 | 3.68 | 61.48 | 63.67 | 2.63 | 7.99 | 3.35 | 6.66 | 0.5374 | 0.00 | -1.03 | 0.9219 | -62.48 | 2.19 | -2.97 | -- |
| Enovis Corp | 1.82bn | -103.33m | 2.45bn | 6.55k | -- | 0.7411 | 18.07 | 1.35 | -1.89 | -1.50 | 33.29 | 60.33 | 0.3717 | 1.49 | 5.49 | 277,452.20 | -2.10 | -0.3569 | -2.32 | -0.41 | 58.12 | 48.19 | -5.66 | -1.06 | 1.03 | 0.9243 | 0.2879 | -- | 9.22 | -4.89 | -40.29 | -- | 11.91 | -- |
| Tandem Diabetes Care Inc | 770.01m | -141.45m | 2.53bn | 2.40k | -- | 10.40 | -- | 3.28 | -2.17 | -2.17 | 11.82 | 3.76 | 0.8126 | 2.74 | 8.35 | 320,837.10 | -14.93 | -10.08 | -18.48 | -12.23 | 49.28 | 51.77 | -18.37 | -11.59 | 3.01 | -- | 0.5884 | -- | -6.68 | 32.39 | -135.33 | -- | 76.81 | -- |
Data as of Jul 03 2024. Currency figures normalised to UFP Technologies Inc's reporting currency: US Dollar USD
